Lingli Zeng

Title: Lingli Zeng: Innovator in Polypeptide Research

Introduction

Lingli Zeng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of polypeptide conjugates and methods for their production and purification. With a total of two patents to his name, Zeng's work is paving the way for advancements in medical treatments.

Latest Patents

Zeng's latest patents include innovative approaches to polypeptide conjugates. One patent focuses on polypeptide conjugates comprising GLP-1 receptor agonists and peptide linkers, along with pharmaceutical compositions that utilize these conjugates for treating various diseases. Another patent details methods for the production and purification of polypeptides, specifically through the use of fusion proteins that enhance solubility and facilitate the expression of target peptides.

Career Highlights

Throughout his career, Lingli Zeng has worked with esteemed institutions such as Tsinghua University and Beijing Ql Biopharmaceutical Co., Ltd. His research has garnered attention for its potential applications in therapeutic settings, particularly in the treatment of metabolic disorders.

Collaborations

Zeng has collaborated with notable colleagues, including Zhanglin Lin and Wanghui Xu. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Lingli Zeng's innovative work in polypeptide research highlights his role as a key inventor in the biopharmaceutical field. His contributions are expected to have a lasting impact on medical treatments and therapeutic strategies.